Literature DB >> 16823396

Increased skewing of X chromosome inactivation in Rett syndrome patients and their mothers.

Gun Peggy S Knudsen1, Tracey C S Neilson, June Pedersen, Alison Kerr, Marianne Schwartz, Maj Hulten, Mark E S Bailey, Karen Helene Orstavik.   

Abstract

Rett syndrome is a largely sporadic, X-linked neurological disorder with a characteristic phenotype, but which exhibits substantial phenotypic variability. This variability has been partly attributed to an effect of X chromosome inactivation (XCI). There have been conflicting reports regarding incidence of skewed X inactivation in Rett syndrome. In rare familial cases of Rett syndrome, favourably skewed X inactivation has been found in phenotypically normal carrier mothers. We have investigated the X inactivation pattern in DNA from blood and buccal cells of sporadic Rett patients (n=96) and their mothers (n=84). The mean degree of skewing in blood was higher in patients (70.7%) than controls (64.9%). Unexpectedly, the mothers of these patients also had a higher mean degree of skewing in blood (70.8%) than controls. In accordance with these findings, the frequency of skewed (XCI > or =80%) X inactivation in blood was also higher in both patients (25%) and mothers (30%) than in controls (11%). To test whether the Rett patients with skewed X inactivation were daughters of skewed mothers, 49 mother-daughter pairs were analysed. Of 14 patients with skewed X inactivation, only three had a mother with skewed X inactivation. Among patients, mildly affected cases were shown to be more skewed than more severely affected cases, and there was a trend towards preferential inactivation of the paternally inherited X chromosome in skewed cases. These findings, particularly the greater degree of X inactivation skewing in Rett syndrome patients, are of potential significance in the analysis of genotype-phenotype correlations in Rett syndrome.

Entities:  

Mesh:

Year:  2006        PMID: 16823396     DOI: 10.1038/sj.ejhg.5201682

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  23 in total

1.  Correlation between clinical severity in patients with Rett syndrome with a p.R168X or p.T158M MECP2 mutation, and the direction and degree of skewing of X-chromosome inactivation.

Authors:  Hayley Archer; Julie Evans; Helen Leonard; Lyn Colvin; David Ravine; John Christodoulou; Sarah Williamson; Tony Charman; Mark E S Bailey; Julian Sampson; Nicholas de Klerk; Angus Clarke
Journal:  J Med Genet       Date:  2006-08-11       Impact factor: 6.318

2.  Two sisters with Rett syndrome and non-identical paternally-derived microdeletions in the MECP2 gene.

Authors:  Lyndon G Rosser; Shane McKee; David S Millar; Hayley Archer; James Hughes; Rachel Butler; Nadia Chuzhanova; David N Cooper; Lazarus P Lazarou
Journal:  Genomic Med       Date:  2008-09-20

Review 3.  Epigenetic and Cellular Diversity in the Brain through Allele-Specific Effects.

Authors:  Wei-Chao Huang; Kathleen Bennett; Christopher Gregg
Journal:  Trends Neurosci       Date:  2018-08-08       Impact factor: 13.837

4.  Female Mecp2(+/-) mice display robust behavioral deficits on two different genetic backgrounds providing a framework for pre-clinical studies.

Authors:  Rodney C Samaco; Christopher M McGraw; Christopher S Ward; Yaling Sun; Jeffrey L Neul; Huda Y Zoghbi
Journal:  Hum Mol Genet       Date:  2012-10-01       Impact factor: 6.150

5.  Tsix-Mecp2 female mouse model for Rett syndrome reveals that low-level MECP2 expression extends life and improves neuromotor function.

Authors:  Lieselot L G Carrette; Roy Blum; Weiyuan Ma; Raymond J Kelleher; Jeannie T Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-23       Impact factor: 11.205

6.  Position effect on FGF13 associated with X-linked congenital generalized hypertrichosis.

Authors:  Gina M DeStefano; Katherine A Fantauzzo; Lynn Petukhova; Mazen Kurban; Marija Tadin-Strapps; Brynn Levy; Dorothy Warburton; Elizabeth T Cirulli; Yujun Han; Xiaoyun Sun; Yufeng Shen; Maryam Shirazi; Vaidehi Jobanputra; Rodrigo Cepeda-Valdes; Julio Cesar Salas-Alanis; Angela M Christiano
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-19       Impact factor: 11.205

7.  A skewed view of X chromosome inactivation.

Authors:  Jakub Minks; Wendy P Robinson; Carolyn J Brown
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

8.  MECP2 promoter methylation and X chromosome inactivation in autism.

Authors:  Raman P Nagarajan; Katherine A Patzel; Michelle Martin; Dag H Yasui; Susan E Swanberg; Irva Hertz-Picciotto; Robin L Hansen; Judy Van de Water; Isaac N Pessah; Ruby Jiang; Wendy P Robinson; Janine M LaSalle
Journal:  Autism Res       Date:  2008-06       Impact factor: 5.216

Review 9.  X chromosome inactivation and autoimmunity.

Authors:  Wesley H Brooks
Journal:  Clin Rev Allergy Immunol       Date:  2010-08       Impact factor: 8.667

Review 10.  Sex differences in Mecp2-mutant Rett syndrome model mice and the impact of cellular mosaicism in phenotype development.

Authors:  Mayara C Ribeiro; Jessica L MacDonald
Journal:  Brain Res       Date:  2020-01-02       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.